Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$482K Sell
1,144
-39
-3% -$15.5K 0.02% 197
2026
Q2
$429K Hold
1,183
– – 0.01% 207
2026
Q1
$416K Buy
1,183
+1
+0.1% +$356 0.02% 201
2025
Q4
$387K Buy
1,182
+90
+8% +$28.5K 0.01% 212
2025
Q3
$308K Buy
1,092
+235
+27% +$68.2K 0.01% 224
2025
Q2
$239K Buy
857
+4
+0.5% +$1.13K 0.01% 237
2025
Q1
$262K Hold
853
– – 0.01% 217
2024
Q4
$221K Buy
853
+1
+0.1% +$297 0.01% 239
2024
Q3
$275K Hold
852
– – 0.01% 215
2024
Q2
$266K Buy
852
+1
+0.1% +$294 0.01% 208
2024
Q1
$242K Buy
+851
New +$249K 0.01% 196
2020
Q4
– Sell
-1,278
Closed -$325K – 148
2020
Q3
$325K Sell
1,278
-376
-23% -$93.1K 0.03% 111
2020
Q2
$390K Sell
1,654
-9
-0.5% -$2.05K 0.04% 92
2020
Q1
$337K Buy
1,663
+109
+7% +$23.8K 0.04% 94
2019
Q4
$375K Buy
1,554
+318
+26% +$70.1K 0.04% 85
2019
Q3
$239K Buy
1,236
+59
+5% +$11.3K 0.02% 107
2019
Q2
$217K Sell
1,177
-172
-13% -$30.8K 0.02% 105
2019
Q1
$256K Buy
1,349
+172
+15% +$32.8K 0.03% 108
2018
Q4
$229K Hold
1,177
– – 0.03% 107
2018
Q3
$244K Hold
1,177
– – 0.03% 112
2018
Q2
$217K Hold
1,177
– – 0.03% 107
2018
Q1
$201K Buy
1,177
+325
+38% +$59.7K 0.03% 105
2017
Q4
$148K Buy
+852
New +$151K 0.02% 115
2017
Q3
– Sell
-3,713
Closed -$639K – 130
2017
Q2
$639K Buy
+3,713
New +$604K 0.11% 62

Other funds holding AMGN

Welch Group's AMGN Position: Q3 2026 in Review

Welch Group reduced its Amgen (AMGN) stake by 3.3% in Q3 2026, selling an estimated $15.5K and leaving 1,144 shares worth $482K. The position accounts for 0.02% of the portfolio, ranked #197.

Welch Group first reported a position in AMGN in Q2 2017 and has held it in 24 quarters since. The position peaked at $639K in Q2 2017. 1,418 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Welch Group held 1,144 shares of Amgen worth $482K as of Q3 2026.
  • Welch Group sold 39 Amgen shares in Q3 2026, an estimated $15.5K.
  • Amgen made up 0.02% of Welch Group's portfolio in Q3 2026, its #197 holding.
  • Welch Group first reported a position in Amgen in Q2 2017 and has held it in 24 quarters since.
  • Welch Group's Amgen position peaked at $639K in Q2 2017.
  • 1,418 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.